{"id":"W2514122689","doi":"10.1186/s12931-016-0425-5","title":"Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review","year":2016,"lang":"en","type":"review","venue":"Respiratory Research","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Pfizer Canada; Novartis Pharma; Grifols; Glenmark Pharmaceuticals; GlaxoSmithKline; Merck Canada; Teva Pharmaceutical Industries; Genentech; AstraZeneca; Pfizer","keywords":"Medicine; Lama; Exacerbation; Bronchodilator; COPD; Bronchiectasis; Bronchodilation; Chronic bronchitis; Azithromycin; Bronchodilator Agents; Intensive care medicine; Bronchitis; Internal medicine; Asthma; Antibiotics; Lung","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001240996,0.0008522738,0.001947031,0.002607371,0.0003630015,0.001587338,0.001172968,0.001317989,0.003874345],"category_scores_gemma":[0.00481355,0.000295952,0.00185586,0.002381211,0.0004081673,0.001410613,0.0007618959,0.001309107,0.0006815767],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006509533,"about_ca_system_score_gemma":0.001745542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001369723,"about_ca_topic_score_gemma":0.002546374,"domain_scores_codex":[0.999328,0.0001531891,0.0002413389,0.00009798093,0.0001444058,0.00003511991],"domain_scores_gemma":[0.9972793,0.002025595,0.0003733973,0.00003794975,0.0002372529,0.00004642133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002573838,0.00008482326,0.0003333371,0.3475241,0.0009288153,0.0002054134,0.0001564988,0.0002756815,0.0003543472,0.002218665,0.01812501,0.629536],"study_design_scores_gemma":[0.0001582625,0.0003956247,0.003780692,0.3943492,0.006575465,0.003093473,0.0003186596,0.0002479524,0.0003300718,0.002358712,0.5883228,0.00006904681],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007925542,0.99935,0.00003737774,0.0001759173,0.00009194912,0.00001100829,0.0000246543,0.000002099678,0.0002277932],"genre_scores_gemma":[0.0007216908,0.9987059,0.0001060657,0.0002344163,0.0001178275,0.00001813025,0.00003140601,8.477271e-7,0.00006379439],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003874345,"threshold_uncertainty_score":0.01296091,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1972340919198312,"score_gpt":0.5132719802528826,"score_spread":0.3160378883330514,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}